• 대한약학회:학술대회논문집
• /
• 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
• /
• pp.367.2-367.2
• /
• 2002

Cnidium Rhizome is a frequently prescribed herbal medicine in Korea, Japan as well as China, which has been successfully used in these countries for the treatment of diseases related to. gynecology, blood circulations and dental troublers in the name of 천궁. And it is circulated as the same chinese character, which is 천궁, although original plants are different as Cnidium officinale in pharmacopoeia of Korea or Japan and Ligusticum chuanxiong Hort. In that of China. (omitted)

• 대한약학회:학술대회논문집
• /
• 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
• /
• pp.418.2-418.2
• /
• 2002

With the Sunshine policy. exchange of goods and cultures inter Koreas is broaden and expectancy of reunification is getting higher. Especially. medical supplies and medicines is one of the biggest parts in the exchanges. So. need for preparing new medical administration system for reunification is needed. We are going to compare inter Koreas drug administration system in medical services. (omitted)

• 대한약학회:학술대회논문집
• /
• 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.1
• /
• pp.283.1-283.1
• /
• 2003

This study was designed to develop and validate an isocratic reversed phase high performance liquid chromatographic(HPLC) method for the quantitation of sobrerol in drug preparations, and obtain the data pool that can be used in the revision of pharmacopoeia. The separation of sobrerol and the other compounds (S-carboxymethylcysteine, acetaminophen, methyl paraben, propyl paraben, and sobrerol degradants) was achieved in a C18 column with an acetonitrile-methanol-water(24.5:10.5:65.0) mobile phase. (omitted)

• 대한한의학회지
• /
• 제36권4호
• /
• pp.56-68
• /
• 2015

Objectives: This study investigated quality among three herb medicine extract granules(DSGOST) which were made from different companies to check quality control of herb medicine extract granules. Methods: we selected three DSGOST extract granules which were made from different companies. And we experimented extract granules by method from K.P(Korean Pharmacopoeia), K.H.P(Korean Herbal Pharmacopoeia) of KFDA. Results: In qualitative analysis of DSGOST, we indentified Akebiae Caulis (木通), Asari Herba Cum Radix (細辛), Evodiae Fructus (吳茱萸) in three different DSGOST extract granules. In quantitative analysis of DSGOST, Medication A,B,C contained similar content of Paeoniflorin & Glycyrrhizic acid. However Medication B contains especially lowest value of Cinnamic acid & total Decursin. Conclusions: Herb medicine extract granules have different contents of ingredients although those were made by same prescription. And these differences may influence medicinal effect to patients. So we need to make system of quality control with various research of quantitative & qualitative analysis about herb medicine extract granules.

• 한국자원식물학회지
• /
• 제30권1호
• /
• pp.58-77
• /
• 2017

본 연구는 노추산(정선군, 강릉시)지역에 대하여 2014년 4월부터 2015년 10월까지 총 7회에 걸쳐 관속식물 분포를 조사하였다. 전체 조사된 분류군은 89과 304속 448종 4아종 57변종 6품종으로 총 515분류군이 자생하는 것으로 확인되었다. 주요 식물로 한국특산식물이 11분류군, 산림청지정 희귀식물 중 위기종이 1분류군, 취약종이 3분류군, 약관심종이 10분류군, 환경부지정 식물구계학적 특정식물 중 4등급종이 11분류군, 3등급종이 30분류군으로 확인되었다. 귀화식물은 총 24분류군으로서 귀화율은 4.6%, 도시화지수 7.5%로 나타났다. 그밖에 대한약전 및 대한약전외한약(생약)규격집에 수재된 약용식물은 67분류군으로 조사되었다.

• 약학회지
• /
• 제57권4호
• /
• pp.258-264
• /
• 2013

Herbal medicine has been traditionally used in Asian countries for a long time. Many pharmacological effects are identified in the herbs and these herbs are believed to be safe for human. However, the safety or adverse effect of some traditional herbal medicines has not been established. We have chosen Cyperi rhizoma based on the Korea Herbal Pharmacopoeia and which have been widely used for an anti-inflammatory effect in Korea. The object of the study was to evaluate safety of Cyperi rhizoma in rats. The aqueous extract of Cyperi rhizoma was prepared according to the standard hot water extraction method of the Korea Pharmacopoeia. In the sub-chronic study, the aqueous extract of Cyperi rhizoma was orally administered once daily as 0, 125, 250, 500, 1000 and 2000 mg/kg/day to male and female F344 rats for 13 weeks. There were no treatment related abnormalities in mortality, clinical signs, food consumption, ophthalmologic examination, hematology, serum chemistry, urinalysis, gross observation, organ weight and histopathologic examination. In conclusion, The NOAEL (No Observed Adverse Effect Level) for Cyperi rhizoma aqueous extract was determined as more than 2000 mg/kg/day in the present experimental condition.

• 한국자원식물학회지
• /
• 제28권2호
• /
• pp.178-192
• /
• 2015

본 연구는 능경봉(평창군, 강릉시)지역에 대하여 2008년 8월과 2013년 4월부터 동년 10월까지 총 7회에 걸쳐 관속식물 분포를 조사하였다. 전체 조사된 분류군은 75과 261속 383종 4아종 48변종 5품종으로 총 440분류군이 자생하는 것으로 확인되었다. 주요 식물로 한국특산식물이 15분류군, 산림청지정 희귀식물 중 약관심종이 11분류군, 환경부 지정 식물구계학적 특정식물 중 4등급이 11분류군, 3등급이 22분류군으로 확인되었다. 귀화식물은 총 29분류군으로서 귀화율은 6.6%, 도시화지수 9.0%로 나타났다. 그밖에 대한약전 및 대한약전외한약(생약)규격집에 수재된 약용식물은 60분류군으로 조사되었다.

• 인삼문화
• /
• 제6권
• /
• pp.80-104
• /
• 2024

인삼은 우리나라를 대표하는 약용작물로 남한뿐만 아니라 북한에서도 매우 중요하게 취급되고 있다. 그러나 북한에 대한 정보 접근이 어렵기 때문에 실제 북한에서 인삼의 재배, 연구와 개발 동향, 관련 산업 현황에 대해서는 잘 알려지지 않고 있다. 본 논문에서는 비록 제한적이긴 하나 구할 수 있는 서지 자료를 통해 북한에서의 인삼 산업 현황과 연구 동향을 파악하고자 하였다. 북한약전에는 인삼이 "고려인삼"으로 수재되어 있으며 '개성지방에서 재배한 6년생 인삼의 뿌리'로 정의하고 있다. 또한 북한약전에는 22종의 인삼제제가 수재되어 있다. 북한에서는 필수약품(2002) 중 건위소화약, 지사약, 보약 등 10개 약품에 인삼이 들어가고, 그 외에도 다양한 건강보조식품과 화장품, 치약 등이 개발되어 유통·판매되고 있다. 2014년 이후 북한에서 인삼 산업과 연구가 전반적으로 활발해지고 있다. 이때 개성의 인삼재배지역을 대폭 확장하고 설비를 보수하였다. 2016년, 개성고려인삼가공공장을 무균화, 현대화, 무진화된 설비로 정비하여 가동 중이라고 한다. 2017년 이후 품질관리 연구에 관심을 돌려 2019년 품질관리규정과 인증제를 도입하기에 이르렀다. 1990년대에 인삼 제품개발 연구가 많았고 2000년부터 인삼의 약리작용 및 치료·임상연구에 대한 연구가 보고되었다. 또한, 수확량을 높이기 위한 인삼재배와 인삼가공업 관련 연구가 중시되고 있다. 인삼은 우리나라를 대표하는 약용작물이라는 점, 남과 북이 모두 중요시하고 있다는 점, 남과 북이 상호 협력하면 큰 시너지 효과를 얻을 수 있다는 점에서 남북 교류협력에 있어서 매우 적합한 소재이다.

• Bulletin of the Korean Chemical Society
• /
• 제29권6호
• /
• pp.1185-1189
• /
• 2008

Two HPLC methods such as cefadroxil and cefalexin methods were compared in their performance for the quantitative analysis of the content and purity of $\beta$ -lactamic antibiotic, cefradine, for six bulk drug samples. Between the two methods, the cefadroxil method prescribed by the European Pharmacopoeia (EP) for the determination of impurities in cefradoxil was superior to the cefalexin method prescribed by the EP and by the United States Pharmacopeia (USP) for the determination of cefalexin impurity in cefradine in terms of the greater stability of the chromatogram baselines and the higher precision, i.e., the lower % relative standard deviation (RSD). Based on the comparison of the two HPLC methods, the cefadroxil method was recommended to replace the TLC method, which has been prescribed by the EP as the official method for determination of extraneous impurities in cefradine.

• KSBB Journal
• /
• 제29권5호
• /
• pp.361-371
• /
• 2014

Mycoplasma is well recognized as one of the most prevalent and serious microbial contaminants of biologic manufacturing processes. Conventional methods for mycoplasma testing, direct culture method and indirect indicator cell culture method, are lengthy, costly and less sensitive to noncultivable species. In this report, we describe a new TaqMan probe-based real-time PCR method for rapid and quantitative detection of mycoplasma contamination during manufacture of biologics. Universal mycoplasma primers were used for mycoplasma PCR and mycoplasma DNA was quantified by use of a specific TaqMan probe. Specificity, sensitivity, and robustness of the real-time PCR method was validated according to the European Pharmacopoeia. The validation results met required criteria to justify its use as a replacement for the culture method. The established real-time PCR assay was successfully applied to the detection of mycoplasma from human keratinocyte and mesenchymal stem cell as well as Vero cell lines artificially infected with mycoplasma. The overall results indicated that this rapid, specific, sensitive, and robust assay can be reliably used for quantitative detection of mycoplasma contamination during manufacture of biologics.